BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 1999
View Archived Issues
Wistar Institute discovers mechanism of action of farnesyltransferase inhibitors
Read More
Company Profile: Resolution Pharmaceuticals
Read More
Celexa approved in Canada
Read More
Medeva: year-end 1998 highlights
Read More
Alza and Sequus registration statement declared effective
Read More
Initial findings reported for CollaGenex's anticancer compound
Read More
Cerus gears up for U.S. phase III trials of platelet pathogen inactivation system
Read More
Fresenius will distribute Genzyme's Sepra products in select European markets
Read More
Sildenafil safe and effective in the treatment of ED in diabetic men
Read More
Vertex patents new series with strong and specific p38 kinase-inhibitory activity
Read More
Lilly's new orally active anticoagulants
Read More
New quinolones from Dong Wha with improved Gram-positive activity and high safety
Read More
Tachykinin antagonists in early development at Pfizer
Read More
DuPont patents novel CRF antagonists for wide range of conditions
Read More
Abbott is also recipient of Prix Galien for its protease inhibitor
Read More
S-5920 superior to methylprednisolone in protecting against ARDS
Read More
Aastrom cord blood therapy kit receives CE Mark approval
Read More
New vasopeptidase inhibitor advances in clinical trials at Bristol-Myers Squibb
Read More
Provigil tablets now available in the U.S.
Read More
PathoGenesis's CF treatment approved in Canada and Argentina
Read More
Potent, selective and orally bioavailable 5-ht6 receptor antagonist presented by SB
Read More
Early clinical results presented for ABX-IL-8 in psoriasis
Read More
Antiarthritic effects, mechanism and GI safety of S-2474 evaluated in rat model
Read More
NeoTherapeutics expands Neotrofin clinical trials internationally
Read More
FDA says KeraVision's treatment for myopia approvable
Read More
Celgene initiates Canadian clinical trial program for chirally pure form of Ritalin
Read More
Ligand introduces second new product this month
Read More